These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22724637)

  • 1. Efficacy of N-(3,4-dimethoxycinnamoyl)-anthranilic acid (tranilast) against eruptive syringoma: report of two cases and review of published work.
    Horie K; Shinkuma S; Fujita Y; Ujiie H; Aoyagi S; Shimizu H
    J Dermatol; 2012 Dec; 39(12):1044-6. PubMed ID: 22724637
    [No Abstract]   [Full Text] [Related]  

  • 2. Solitary mastocytoma treated with tranilast.
    Katoh N; Hirano S; Yasuno H
    J Dermatol; 1996 May; 23(5):335-9. PubMed ID: 8675824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of linear localized scleroderma with the anti-allergic drug, tranilast.
    Taniguchi S; Yorifuji T; Hamada T
    Clin Exp Dermatol; 1994 Sep; 19(5):391-3. PubMed ID: 7525127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-platelet action of an anti-allergic agent, N-(3',4'-dimethoxycinnamoyl)anthranilic acid (tranilast).
    Iwasa Y; Iwasa T; Matsui K; Yoshimura T; Tanaka N; Miyazaki K
    Eur J Pharmacol; 1986 Jan; 120(2):231-4. PubMed ID: 2419148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of granuloma annulare with tranilast.
    Yamada H; Ide A; Sugiura M; Kurihara S; Tajima S
    J Dermatol; 1995 May; 22(5):354-6. PubMed ID: 7545709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of eosinophilic cystitis induced by tranilast.
    Okada H; Minayoshi K; Goto A
    J Urol; 1992 May; 147(5):1366-8. PubMed ID: 1373780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Tranilast [N-(3,4-dimethoxycinnamoyl) anthranilic acid] in secretory otitis media.
    Ogino S; Harada T; Matsunaga T; Tominaga Y
    Ann Allergy; 1992 May; 68(5):407-12. PubMed ID: 1375005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case report of postpubertal eruptive syringoma triggered with antiepileptic drugs.
    Oztürk F; Ermertcan AT; Bilaç C; Temiz P
    J Drugs Dermatol; 2010 Jun; 9(6):707-10. PubMed ID: 20645537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranilast: a review of its therapeutic applications.
    Darakhshan S; Pour AB
    Pharmacol Res; 2015 Jan; 91():15-28. PubMed ID: 25447595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulval syringoma successfully treated with tranilast.
    Iwao F; Onozuka T; Kawashima T
    Br J Dermatol; 2005 Dec; 153(6):1228-30. PubMed ID: 16307668
    [No Abstract]   [Full Text] [Related]  

  • 11. [Generalized eruptive syringoma: case report].
    Silva CS; Souza MB; Lima KA; de Almeida MA; Criado PR
    Dermatol Online J; 2009 Feb; 15(2):7. PubMed ID: 19336024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological properties of N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent. (4).--Anti-inflammatory activity of N-5' (author's transl)].
    Nakazawa M; Yoshimura T; Naito J; Azuma H
    Nihon Yakurigaku Zasshi; 1978 May; 74(4):473-81. PubMed ID: 700512
    [No Abstract]   [Full Text] [Related]  

  • 13. Eruptive syringoma of the penis. A report of 2 cases and a review of the literature.
    Petersson F; Mjörnberg PA; Kazakov DV; Bisceglia M
    Am J Dermatopathol; 2009 Jul; 31(5):436-8. PubMed ID: 19542916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated form of syringoma (eruptive syringoma) sparing the face-a rare presentation causing diagnostic challenge.
    Temam F; Bizuneh E; Leekassa R
    Ethiop Med J; 2008 Jul; 46(3):273-6. PubMed ID: 19271392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double blind controlled trial of N-(3',4'-dimethoxycinnamoyl) anthranilic acid on children with bronchial asthma. N-5' Study Group in Children.
    Shioda H
    Allergy; 1979 Aug; 34(4):213-9. PubMed ID: 391094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solitary syringoma. Report of five cases and clinicopathologic comparison with microcystic adnexal carcinoma of the skin.
    Henner MS; Shapiro PE; Ritter JH; Leffell DJ; Wick MR
    Am J Dermatopathol; 1995 Oct; 17(5):465-70. PubMed ID: 8599451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple unilateral skin tumors suggest type 1 segmental manifestation of familial syringoma.
    Ceulen RP; Van Marion AM; Steijlen PM; Frank J; Poblete-Gutiérrez P
    Eur J Dermatol; 2008; 18(3):285-8. PubMed ID: 18474456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microcystic adnexal carcinoma associated with multiple benign syringomatous proliferations: a report of two cases.
    Liang CA; Busam KJ; Nehal KS
    Dermatol Surg; 2011 Oct; 37(10):1515-8. PubMed ID: 21649791
    [No Abstract]   [Full Text] [Related]  

  • 19. Syringoma resembling confluent and reticulated papillomatosis of Gougerot-Carteaud.
    Lee MW; Goldberg LH; Dorsey K; Baer SC
    Cutis; 1998 Apr; 61(4):227-8. PubMed ID: 9564597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eruptive syringomas.
    Teixeira M; Ferreira M; Machado S; Alves R; Selores M
    Dermatol Online J; 2005 Dec; 11(3):34. PubMed ID: 16409930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.